Sclerosing Agents in the Management of Lymphatic Malformations in Children: A Systematic Review

Systematic review of 48 studies spanning 30 years evaluates sclerotherapy outcomes in 886 pediatric lymphatic malformation patients. Overall success rate of 89% with macrocystic lesions responding better than microcystic variants (89% vs 34% resolution). Analysis examines multiple sclerosing agents, dosing strategies, and complication profiles to guide treatment selection.